Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kimmo Porkka

Showing results (41-50 of 142) with videos related to

Pageof 15
Sort By:
Clinical Pharmacology and Therapeutics|November 10, 2025
Enhancing Severe Neutropenia Prediction: PKPD-Informed Labeling for Machine Learning Models Trained on Real-World DataConor J O'Hanlon, Jonas Denck, Elif Ozkirimli, et al.
Leukemia|June 9, 2019
Elevated expression of S100A8 and S100A9 correlates with resistance to the BCL-2 inhibitor venetoclax in AMLRiikka Karjalainen, Minxia Liu, Ashwini Kumar, et al.
Leukemia|January 13, 2019
Immune cell constitution in bone marrow microenvironment predicts outcome in adult ALLHelena Hohtari, Oscar Brück, Sami Blom, et al.
Leukemia|July 12, 2020
Pan-RAF inhibition induces apoptosis in acute myeloid leukemia cells and synergizes with BCL2 inhibitionMahesh Tambe, Ella Karjalainen, Markus Vähä-Koskela, et al.
Blood Advances|January 10, 2024
Monosomy 7/del(7q) cause sensitivity to inhibitors of nicotinamide phosphoribosyltransferase in acute myeloid leukemiaSamuli Eldfors, Joseph Saad, Nemo Ikonen, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
Sensitivity to ATR-CHK1 pathway inhibition in AML/MDS is enhanced by <i>SRSF2</i> mutations and reduced by RUNX1 lossSamuli Eldfors, Sumit Rai, Vineet Sharma, et al.
Cancer|March 22, 2016
Lymphocytosis after treatment with dasatinib in chronic myeloid leukemia: Effects on response and toxicityCharles A Schiffer, Jorge E Cortes, Andreas Hochhaus, et al.
Future Oncology (London, England)|October 13, 2023
Real-world evidence of multiple myeloma treated from 2013 to 2019 in the Hospital District of Helsinki and Uusimaa, FinlandJohanna Vikkula, Kristiina Uusi-Rauva, Tuuli Ranki, et al.
Leukemia & Lymphoma|August 5, 2017
Chimeric NUP98-NSD1 transcripts from the cryptic t(5;11)(q35.2;p15.4) in adult de novo acute myeloid leukemiaJarno L Kivioja, Jesus M Lopez Martí, Ashwini Kumar, et al.
European Journal of Human Genetics : EJHG|May 5, 2016
Enrichment of rare variants in population isolates: single AICDA mutation responsible for hyper-IgM syndrome type 2 in FinlandLuca Trotta, Timo Hautala, Sari Hämäläinen, et al.
Pageof 15

Showing results (41-50 of 142) with videos related to

Sort By:
Pageof 15
Clinical Pharmacology and Therapeutics|November 10, 2025
Enhancing Severe Neutropenia Prediction: PKPD-Informed Labeling for Machine Learning Models Trained on Real-World DataConor J O'Hanlon, Jonas Denck, Elif Ozkirimli, et al.
Leukemia|June 9, 2019
Elevated expression of S100A8 and S100A9 correlates with resistance to the BCL-2 inhibitor venetoclax in AMLRiikka Karjalainen, Minxia Liu, Ashwini Kumar, et al.
Leukemia|January 13, 2019
Immune cell constitution in bone marrow microenvironment predicts outcome in adult ALLHelena Hohtari, Oscar Brück, Sami Blom, et al.
Leukemia|July 12, 2020
Pan-RAF inhibition induces apoptosis in acute myeloid leukemia cells and synergizes with BCL2 inhibitionMahesh Tambe, Ella Karjalainen, Markus Vähä-Koskela, et al.
Blood Advances|January 10, 2024
Monosomy 7/del(7q) cause sensitivity to inhibitors of nicotinamide phosphoribosyltransferase in acute myeloid leukemiaSamuli Eldfors, Joseph Saad, Nemo Ikonen, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
Sensitivity to ATR-CHK1 pathway inhibition in AML/MDS is enhanced by <i>SRSF2</i> mutations and reduced by RUNX1 lossSamuli Eldfors, Sumit Rai, Vineet Sharma, et al.
Cancer|March 22, 2016
Lymphocytosis after treatment with dasatinib in chronic myeloid leukemia: Effects on response and toxicityCharles A Schiffer, Jorge E Cortes, Andreas Hochhaus, et al.
Future Oncology (London, England)|October 13, 2023
Real-world evidence of multiple myeloma treated from 2013 to 2019 in the Hospital District of Helsinki and Uusimaa, FinlandJohanna Vikkula, Kristiina Uusi-Rauva, Tuuli Ranki, et al.
Leukemia & Lymphoma|August 5, 2017
Chimeric NUP98-NSD1 transcripts from the cryptic t(5;11)(q35.2;p15.4) in adult de novo acute myeloid leukemiaJarno L Kivioja, Jesus M Lopez Martí, Ashwini Kumar, et al.
European Journal of Human Genetics : EJHG|May 5, 2016
Enrichment of rare variants in population isolates: single AICDA mutation responsible for hyper-IgM syndrome type 2 in FinlandLuca Trotta, Timo Hautala, Sari Hämäläinen, et al.
Pageof 15